VRKSX Mutual Fund

VRKSX Mutual Fund

NAV$10.06
See how much of VRKSX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jun 30, 2026

Net Assets
$4M
Expense Ratio
0.89%
Dividend Yield (Current)
-
Holdings
28
Inception Date
Dec 8, 2020
Fund Family
Virtus Investment Partners
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

YTD-0.49%
1 Year-9.29%
3 Year+2.35%
5 Year-1.63%

Asset Allocation

Stocks: 100.00%
See how much of VRKSX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
WSTWest Pharmaceutical Services Inc6.36%
HNGEHinge Health Inc Ordinary Shares - Class A6.03%
AAONAaon, Inc.5.43%
HEI.AHeico Corp. Cl. A5.41%
TDYTeledyne Technologies Inc4.83%
Top 10 Concentration: 49.34%Report Date: Jun 30, 2026
Download all 28 holdings for VRKSX
CSV export with sector, industry & share changes
Get CSV

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

VRKSX Mutual Fund Overview

VRKSX Mutual Fund (Virtus KAR Small-Mid Cap Growth Fund Class R6) is managed by Virtus Investment Partners with $4.1M in net assets. VRKSX expense ratio is 0.89%, holding 28 positions across sectors including Industrials, Information Technology, Health Care. Inception date: 2020-12-08.

VRKSX performance shows a YTD return of -0.49%. The 1-year return is -9.29% and the 5-year return is -1.63%.

VRKSX top holdings include West Pharmaceutical Services Inc (6.4%), Hinge Health Inc Ordinary Shares - Class A (6.0%), Aaon, Inc. (5.4%), Heico Corp. Cl. A (5.4%), Teledyne Technologies Inc (4.8%). Go to all VRKSX holdings, VRKSX sectors, or VRKSX dividends.

VRKSX can be compared against other funds. Use VRKSX overlap to find shared positions, or VRKSX vs another fund for a side-by-side view. VRKSX alternatives are available via the screener, along with tax-loss harvesting opportunities.